BRK-B vs HYNE
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Hoyne Bancorp exhibits a severe valuation disconnect, with a current price of $16.09 vastly exceeding its Graham Number ($3.67) and Intrinsic Value ($0.21). While the Piotroski F-Score of 4/9 indicates stable financial health, the company's profitability is negligible, evidenced by an ROE of 0.19% and an astronomical P/E ratio of 536.33. Despite strong top-line revenue growth of 51.4%, this growth is not translating into meaningful earnings. The stock is trading at a significant premium to its fundamental value despite a bearish technical trend.
Compare Another Pair
Related Comparisons
BRK-B vs HYNE: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Hoyne Bancorp, Inc. (HYNE) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.